Patent details

EP2027870 Title: Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin

Basic Information

Publication number:
EP2027870
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP080757313
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin
French Title of Invention:
Régulation de la glycémie dans le traitement du diabète au moyen de l'insuline administrée par voie pulmonaire en association avec de l'insuline basale
German Title of Invention:
Kontrolle des Blutzuckers bei der Diabetesbehandlung unter Verwendung von über die Lunge verabreichtem Insulin in Kombination mit Basalinsulin
SPC Number:

Dates

Filing date:
31/03/2006
Grant date:
16/06/2010
EP Publication Date:
16/06/2010
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/02/2009
EP B1 Publication Date:
16/06/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
31/03/2011
Expiration date:
31/03/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/03/2006
 
 

Name:
MannKind Corporation
Address:
28903 North Avenue Paine, Valencia, CA 91355, United States (US)

Inventor

1

Name:
Cheatham Wayman Wendell
Address:
United States (US)

2

Name:
Boss Anders
Address:
United States (US)

Priority

1

Priority Number:
667393 P
Priority Date:
31/03/2005
Priority Country:
United States (US)

2

Priority Number:
329686
Priority Date:
10/01/2006
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/28;
Filing date Document type Number of pages